3-CYCLYL-2- (4-SULFAMO YL-PHENYL) -N-CYCLYL-PROPIONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF IMPAIRED GLUCOSE TOLERANCE AND DIABETES

Title:

3-CYCLYL-2- (4-SULFAMO YL-PHENYL) -N-CYCLYL-PROPIONAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF IMPAIRED GLUCOSE TOLERANCE AND DIABETES

Document Type and Number:

WIPO Patent Application WO2007041365

Kind Code:

B1

Abstract:

The present invention provides compounds of the formula (I); which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, type 2 diabetes and obesity.

Inventors:

BEBERNITZ GREGORY RAYMOND (US)

Application Number:

PCT/US2006/038200

Publication Date:

August 16, 2007

Filing Date:

September 28, 2006

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NOVARTIS AG (CH)
NOVARTIS PHARMA GMBH (AT)
BEBERNITZ GREGORY RAYMOND (US)

International Classes:

C07D211/62; C07D213/75; C07D239/42; C07D241/04; C07D241/20; C07D277/46; C07D277/82; C07D513/04

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS AND COMPOSITIONS FOR MODULATING IMMUNE TOLERANCE

Next Patent: SULFONAMIDE DERIVATIVES AS GLYCOKINASE ACTIVATORS USEFUL IN THE TREATMENT OF TYPE 2 DIABETES